Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
|Active Ingredients:||Naphazoline hydrochloride 0.025%w/v
Pheniramine maleate 0.3%w/v
|Dosage Form:||Eye drops, solution|
|New Zealand Sponsor:||Alcon Laboratories (New Zealand) Limited|
|Manufacturers:||Alcon Couvreur NV, Puurs, Belgium
Alcon Singapore Manufacturing Pte Limited, Tuas, Singapore
Dated this 31st day of October 2022.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).